Developer docs
API playgroundTry for free, no card

Search company profiles

Avidas Pharmaceuticals

Full company profile

uuid000hajg

Namestring
Avidas Pharmaceuticals
Legal namestring
Avidas Pharmaceuticals LLC
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Avidas Pharmaceuticals LLC is a privately-held specialty pharmaceutical company headquartered in Doylestown, Pennsylvania, focused on age-related disorders and diseases in dermatology, endocrinology, and women's healthcare. The company does not develop or manufacture its own molecules; rather, it identifies and acquires novel specialty therapeutics, including late-stage development drugs, through in-licensing arrangements and partnership-driven acquisitions. Founded and led by Margie Gardner, whose 25+ years of pharmaceutical experience includes senior commercial leadership roles at SmithKline, GlaxoSmithKline, Merck, and most recently as Senior Vice President at King Pharmaceuticals, the company positions its commercialization expertise as its primary value proposition to potential licensors.

Avidas generates revenue by commercializing its in-licensed product portfolio through a US-wide direct field sales force, with 25+ sales territory positions open across major metropolitan markets and regional sales leadership overseeing the Northeast and Southwest. The go-to-market motion is enterprise field sales targeting healthcare providers in its three therapeutic focus areas, with supporting activities in product expertise, medical education, and customer service. The company is not vertically integrated, has no disclosed institutional investors or funding rounds, and operates entirely on a domestic US basis with no international footprint signaled.

The business model is asset-light and partnership-dependent: Avidas's value capture is tied to its ability to source attractive in-licensing opportunities, execute US commercial launches, and grow specialty pharma sales. No specific in-licensed products are named in the available data, and no revenue, funding, or customer concentration figures are disclosed. The company's stated growth strategy is to continuously expand its in-licensed portfolio within and potentially beyond its three named therapeutic areas, leveraging its commercial infrastructure and management's track record of product launches.

Short descriptiontext

Avidas Pharmaceuticals is a privately-held US specialty pharmaceutical company that in-licenses and commercializes novel therapeutics in dermatology, endocrinology, and women's healthcare via a nationwide direct field sales force serving healthcare providers and patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDoylestown, United States
HQ citystring
Doylestown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, dermatology therapeutics, women's healthcare drugs, endocrinology medicines, in-licensed pharmaceuticals
Industry3 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Commercialization
TypeLicensing Royalties
Description

Avidas generates revenue through commercializing specialty pharmaceutical products acquired via in-licensing arrangements and partnerships. The company identifies and acquires novel specialty therapeutics including late-stage development drugs, then grows sales through their commercial infrastructure.

avidaspharma.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Avidas Pharmaceuticals identifies and acquires novel specialty therapeutics (including late-stage development drugs) in dermatology, endocrinology, and women's healthcare through in-licensing and partnerships, then commercializes these branded pharmaceutical products across the United States using a field-based direct sales force.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Avidas Pharmaceuticals is a privately-held specialty pharmaceutical company focused on identifying, acquiring, and commercializing novel specialty therapeutics in dermatology, endocrinology, and women's healthcare. The company does not manufacture its own products but rather operates as an in-licensing and partnership-driven entity, seeking to in-license branded pharmaceutical products including late-stage development drugs. The company's business model centers on strategic partnerships and acquisitions to grow specialty medicine portfolios rather than operating a unified product platform.

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Avidas is actively seeking partnership opportunities for specialty product licenses or acquisitions in dermatology, endocrinology, and women's healthcare. The company positions itself as an outstanding partner for companies seeking to drive sales of innovative specialty products, offering commercialization expertise and a successful track record of product launches.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Specialty pharmaceutical company focused on women's health with a commercial sales force targeting healthcare providers, directly overlapping Avidas' women's healthcare vertical and in-licensing/commercialization model.

TypeBroad incumbent
Description

Large women's health and biosimilars specialty pharma formed from Merck's spinoff, serving OB/GYNs and endocrinologists with a broad portfolio — competes with Avidas' women's healthcare and endocrinology focus at a much larger scale.

TypeBroad incumbent
Description

Global dermatology specialty pharmaceutical leader with established US sales infrastructure, competing directly for prescribers in Avidas' dermatology vertical — though with a much broader product portfolio.

TypeDirect peer
Description

Specialty pharmaceutical company focused on dermatology and neurology with an active US commercial sales force, comparable to Avidas in scale and therapeutic category overlap, particularly in dermatology.

TypeDirect peer
Description

Privately-held specialty pharmaceutical company commercializing niche therapeutics across multiple therapeutic categories with US sales coverage — closely mirrors Avidas' in-licensing/commercialization model and specialty focus.

TypeDirect peer
Description

Specialty pharma with historic focus on women's health and dermatology transdermal products, operating through US physician-channel sales — directly comparable therapeutic verticals and commercialization approach.

7Endo International
TypeBroad incumbent
Description

Specialty pharmaceutical company with established franchises in women's health, endocrinology, and dermatology — competing with Avidas across all three therapeutic areas, but at materially larger scale.

TypeBroad incumbent
Description

Diversified specialty and generic pharmaceutical manufacturer with US commercial infrastructure, overlapping with Avidas in specialty therapeutics distribution and the same therapeutic categories.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Avidas Pharmaceuticals

Specialty Pharmaceuticalsavidaspharma.com

Avidas Pharmaceuticals is a privately-held US specialty pharmaceutical company that in-licenses and commercializes novel therapeutics in dermatology, endocrinology, and women's healthcare via a nationwide direct field sales force serving healthcare providers and patients.

What Avidas Pharmaceuticals does

Avidas Pharmaceuticals LLC is a privately-held specialty pharmaceutical company headquartered in Doylestown, Pennsylvania, focused on age-related disorders and diseases in dermatology, endocrinology, and women's healthcare. The company does not develop or manufacture its own molecules; rather, it identifies and acquires novel specialty therapeutics, including late-stage development drugs, through in-licensing arrangements and partnership-driven acquisitions. Founded and led by Margie Gardner, whose 25+ years of pharmaceutical experience includes senior commercial leadership roles at SmithKline, GlaxoSmithKline, Merck, and most recently as Senior Vice President at King Pharmaceuticals, the company positions its commercialization expertise as its primary value proposition to potential licensors.

Avidas generates revenue by commercializing its in-licensed product portfolio through a US-wide direct field sales force, with 25+ sales territory positions open across major metropolitan markets and regional sales leadership overseeing the Northeast and Southwest. The go-to-market motion is enterprise field sales targeting healthcare providers in its three therapeutic focus areas, with supporting activities in product expertise, medical education, and customer service. The company is not vertically integrated, has no disclosed institutional investors or funding rounds, and operates entirely on a domestic US basis with no international footprint signaled.

The business model is asset-light and partnership-dependent: Avidas's value capture is tied to its ability to source attractive in-licensing opportunities, execute US commercial launches, and grow specialty pharma sales. No specific in-licensed products are named in the available data, and no revenue, funding, or customer concentration figures are disclosed. The company's stated growth strategy is to continuously expand its in-licensed portfolio within and potentially beyond its three named therapeutic areas, leveraging its commercial infrastructure and management's track record of product launches.

Avidas Pharmaceuticals firmographics

Firmographics
Name
Avidas Pharmaceuticals
Legal name
Avidas Pharmaceuticals LLC
Website
https://avidaspharma.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Avidas Pharmaceuticals is a privately-held US specialty pharmaceutical company that in-licenses and commercializes novel therapeutics in dermatology, endocrinology, and women's healthcare via a nationwide direct field sales force serving healthcare providers and patients.
Ownership category
akta.pro rank

Avidas Pharmaceuticals industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAK
Dermatology & Aesthetics Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Specialty pharmaceuticals
  • Dermatology therapeutics
  • Women's healthcare drugs
  • Endocrinology medicines
  • In-licensed pharmaceuticals

Where Avidas Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Doylestown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Avidas Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. Pharmaceutical Product Commercialization: Avidas generates revenue through commercializing specialty pharmaceutical products acquired via in-licensing arrangements and partnerships. The company identifies and acquires novel specialty therapeutics including late-stage development drugs, then grows sales through their commercial infrastructure.

Go-to-market motion1 record

Distribution channels1 record

Avidas Pharmaceuticals product offering

Product offering

Core offering

Avidas Pharmaceuticals identifies and acquires novel specialty therapeutics (including late-stage development drugs) in dermatology, endocrinology, and women's healthcare through in-licensing and partnerships, then commercializes these branded pharmaceutical products across the United States using a field-based direct sales force.

Product overview

Avidas Pharmaceuticals is a privately-held specialty pharmaceutical company focused on identifying, acquiring, and commercializing novel specialty therapeutics in dermatology, endocrinology, and women's healthcare. The company does not manufacture its own products but rather operates as an in-licensing and partnership-driven entity, seeking to in-license branded pharmaceutical products including late-stage development drugs. The company's business model centers on strategic partnerships and acquisitions to grow specialty medicine portfolios rather than operating a unified product platform.

Differentiator

Problem solved

Functional benefit

Companies that use Avidas Pharmaceuticals

Customer profile

Segments2 records

Ideal customer profiles2 records

Avidas Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Avidas Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Companies with Specialty Product PortfolioscoreOthersAvidas is actively seeking partnership opportunities for specialty product licenses or acquisitions in dermatology, endocrinology, and women's healthcare. The company positions itself as an outstanding partner for companies seeking to drive sales of innovative specialty products, offering commercialization expertise and a successful track record of product launches.

Recent moves4 records

Expansion highlights4 records

Avidas Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • TherapeuticsMD: Specialty pharmaceutical company focused on women's health with a commercial sales force targeting healthcare providers, directly overlapping Avidas' women's healthcare vertical and in-licensing/commercialization model.
  • Merz Therapeutics: Specialty pharmaceutical company focused on dermatology and neurology with an active US commercial sales force, comparable to Avidas in scale and therapeutic category overlap, particularly in dermatology.
  • Mission Pharmacal: Privately-held specialty pharmaceutical company commercializing niche therapeutics across multiple therapeutic categories with US sales coverage — closely mirrors Avidas' in-licensing/commercialization model and specialty focus.
  • Noven Pharmaceuticals: Specialty pharma with historic focus on women's health and dermatology transdermal products, operating through US physician-channel sales — directly comparable therapeutic verticals and commercialization approach.

Broad incumbents

  • Organon & Co. Large women's health and biosimilars specialty pharma formed from Merck's spinoff, serving OB/GYNs and endocrinologists with a broad portfolio — competes with Avidas' women's healthcare and endocrinology focus at a much larger scale.
  • Galderma: Global dermatology specialty pharmaceutical leader with established US sales infrastructure, competing directly for prescribers in Avidas' dermatology vertical — though with a much broader product portfolio.
  • Endo International: Specialty pharmaceutical company with established franchises in women's health, endocrinology, and dermatology — competing with Avidas across all three therapeutic areas, but at materially larger scale.
  • Amneal Pharmaceuticals: Diversified specialty and generic pharmaceutical manufacturer with US commercial infrastructure, overlapping with Avidas in specialty therapeutics distribution and the same therapeutic categories.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Avidas Pharmaceuticals social profiles

Digital presence

Avidas Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Avidas Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Avidas Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Avidas Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Avidas Pharmaceuticals

What does Avidas Pharmaceuticals do?

Avidas Pharmaceuticals identifies and acquires novel specialty therapeutics (including late-stage development drugs) in dermatology, endocrinology, and women's healthcare through in-licensing and partnerships, then commercializes these branded pharmaceutical products across the United States using a field-based direct sales force.

Is Avidas Pharmaceuticals a public or private company?

Avidas Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Avidas Pharmaceuticals founded?

Avidas Pharmaceuticals was founded in -1. It employs 11 to 50 people.

Where is Avidas Pharmaceuticals based?

Avidas Pharmaceuticals is headquartered in Doylestown, United States, in the North America region.

How does Avidas Pharmaceuticals make money?

One revenue line is on record: pharmaceutical Product Commercialization.

Who are Avidas Pharmaceuticals's main competitors?

Direct peers on record are TherapeuticsMD, Merz Therapeutics, Mission Pharmacal and Noven Pharmaceuticals. Broad incumbents are Organon & Co., Galderma, Endo International and Amneal Pharmaceuticals.

Does Avidas Pharmaceuticals have an API?

No public API is recorded for Avidas Pharmaceuticals.

What industry is Avidas Pharmaceuticals in?

Avidas Pharmaceuticals's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales